Source: Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marie Legendre, Afifaa Butt, Raphaël Borie, Marie-Pierre Debray, Diane Bouvry, Emilie Filhol-Blin, Tifenn Desroziers, Valérie Nau, Bruno Copin, Florence Dastot-Le Moal, Mélanie Héry, Philippe Duquesnoy, Nathalie Allou, Anne Bergeron, Julien Bermudez, Aurélie Cazes, Anne-Laure Chene, Vincent Cottin, Bruno Crestani, Jean-Charles Dalphin, Christine Dombret, Bérénice Doray, Clairelyne Dupin, Violaine Giraud, Anne Gondouin, Laurent Gouya, Dominique Israël-Biet, Caroline Kannengiesser, Aurélie Le Borgne, Sylvie Leroy, Elisabeth Longchampt, Gwenaël Lorillon, Hilario Nunes, Clément Picard, Martine Reynaud-Gaubert, Julie Traclet, Paul de Vuyst, Aurore Coulomb L'Hermine, Annick Clement, Serge Amselem, Nadia Nathan. Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer. Eur Respir J, 56 (6) 2002806; 10.1183/13993003.02806-2020

Member's Comments

No comment yet.

Related content which might interest you: Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 SFTPA mutations in interstitial lung disease (ILD) and lung cancer Source: International Congress 2017 – Rare diseases Year: 2017 The 15q24/25 susceptibility variant for lung cancer and COPD is associated with emphysema Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Classification of different ABCA3 mutations causing interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Cellular consequences of uncharacterized surfactant protein-A2 (SFTPA2)-gene mutations associated with familial IPF and lung cancer Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin Year: 2019 Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer Source: International Congress 2016 – IPF pathogenesis Year: 2016 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Genetic polymorphisms and lung cancer susceptibility in a Brazilian population Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Genetic variations and lung function Source: Eur Respir J 2006; 28: Suppl. 50, 525s Year: 2006 Distinct forms of BARD1 expressed in lung fibrosis and lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006 Genetic studies in paediatric interstitial lung disease Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Functional polymorphism of p53 and CCR5 genes in lung carcinoma and bronchail asthma Source: Eur Respir J 2005; 26: Suppl. 49, 591s Year: 2005 The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Genetic predisposition to nonsmall-cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016